Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
Phase 2
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2005-11-08
- Lead Sponsor
- Zeneus Pharma
- Target Recruit Count
- 45
- Registration Number
- NCT00250874
- Locations
- 🇮🇹
Ospedale Pietrantoni, Forli, Italy
Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.
Phase 2
- Conditions
- Aggressive Non-Hodgkin's Lymphoma in the Elderly.
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2005-10-28
- Lead Sponsor
- Zeneus Pharma
- Target Recruit Count
- 75
- Registration Number
- NCT00244127
- Locations
- 🇮🇹
Universita Degli Studi Di Modena AZ Ospedaliere Policlinico, Modena, Italy
© Copyright 2025. All Rights Reserved by MedPath